Kusajili – Centralise les essais cliniques mondiaux

Pivotal Phase III Trial to Investigate the Efficacy and Safety of an Orodispersible Tablet Vardenafil Versus Placebo in the Treatment of Men With Erectile Dysfunction (ED) - a Fixed-dose, Double-blind, Randomized Multi-center Trial - POTENT I

• Pays Belgium, France, Germany, Netherlands, South Africa, Spain,
• Organes Aucun
• Spécialités Aucun

Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Vardenafil 10 mg Twice Daily to Assess the Effect on Urodynamics in Patients With Overactive Bladder (Detrusor Overactivity)

• Pays Belgium, Canada, Czech Republic, France, Germany, Hungary, Israel, Netherlands, Poland, Portugal, Russian Federation, Spain, Switzerland,
• Organes Aucun
• Spécialités Aucun

Multinational Non-Interventional Study (NIS) of Patients with ST- Segment Elevation Myocardial Infarction Treated with Primary Angioplasty and Concomitant Use of Upstream Antiplatelet Therapy with a Thienopyridine Agent

• Pays Denmark, Finland, France, Germany, Italy, Netherlands, Poland, Spain,
• Organes Aucun
• Spécialités Aucun

European Multinational Registry on Prevention of Thromboembolic Events in Atrial Fibrillation

• Pays Austria, France, Germany, Italy, Spain, Switzerland, United Kingdom,
• Organes Aucun
• Spécialités Aucun

A Single Arm, Multicenter Phase II Trial of RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Cancer

• Pays Belgium, France, Germany, Italy, Poland, Spain,
• Organes Aucun
• Spécialités Aucun

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Trial Investigating Two Doses of EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer (mCRPC)

• Pays Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Spain, United States,
• Organes Aucun
• Spécialités Aucun